Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
7Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
ADC Therapeutics SA (ADCT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
15Total relationships
3Distinct source URLs
10High confidence
0.833Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
ADC Therapeutics SA Suppliers
Ticker
Name
Confidence
Evidence
HEALTHCARE-ROYALTY-MANAGEMENT-LLC
HEALTHCARE-ROYALTY-MANAGEMENT-LLC
80%
The Company is relying on this exemption from registration based in part on representations made in the warrants.
Reciprocal relationship from GHRS graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from GHRS graph: 1 million for the year ended December 31, 2024. This movement is primarily a…
Reciprocal relationship from OCSL graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from OCSL graph: olidated Statements of Cash Flows (in thousands) (unaudited) Six months ende…
Reciprocal relationship from PYXS graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from PYXS graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from PYXS g…
ADC Therapeutics SA Customers
Ticker
Name
Confidence
Evidence
AMERISOURCEBERGEN-CORPORATION
AMERISOURCEBERGEN-CORPORATION
92%
Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 and 2025 are as follows: Three Months Ended March 31, 2026 2025 AmerisourceBergen …
Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 and 2025 are as follows: Three Months Ended March 31, 2026 2025 Cardinal Health 25…
Reciprocal relationship from CAH graph: Reciprocal relationship from ADCT graph: Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 a…
Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 and 2025 are as follows: Three Months Ended March 31, 2026 2025 McKesson 36 % 34 %
Reciprocal relationship from MCK graph: Reciprocal relationship from ADCT graph: Customers from which we derive more than 10% of our total product revenues for the three months ended March 31, 2026 a…
Reciprocal relationship from PYXS graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from PYXS graph: Reciprocal relationship from ADCT graph: Reciprocal relationship from PYXS g…
CAPITAL-RESOURCES
CAPITAL-RESOURCES
62%
by collaborations and royalty financings and sales of ZYNLONTA in the United States. For a description of the Loan Agreement, Amended HCR Agreement and other license and collaboration agreements, see…
ADC Therapeutics SA Debt Obligations
Instrument
Description
Confidence
Evidence
ADCT-DEBT-7505
Warrants outstanding: 27743685
90%
xbrl warrant detail from xbrl 2026-03-31.
ADCT-DEBT
Debt stack $6.2M
90%
Market cache reports total debt of $6.2M.
ADCT-DEBT-7506
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-12-31.
ADC Therapeutics SA Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for ADC Therapeutics SA.
ADC Therapeutics SA Ownership
Holder
Name
Confidence
Evidence
ADCT-OWNER-REDMILE-GROUP-LLC
Redmile Group, LLC
90%
13F overlay lists Redmile Group, LLC as top holder; 118 tracked holders.
